CVE-2026-60846Vulnerability in the Oracle Mobile Application Server product of Oracle E-Business Suite (component: MWA Terminal Server).
Updated under an hour ago ()
Does this affect you?
It affects oracle e-business_suite. Add what you run to find out whether that includes you.
No exploitation reported and no EPSS estimate yet.
Do this next
Free account, 1 product
Vulnerability in the Oracle Mobile Application Server product of Oracle E-Business Suite (component: MWA Terminal Server). Supported versions that are affected are 12.2.3-12.2.15. Easily exploitable vulnerability allows high privileged attacker with network access via HTTP to compromise Oracle Mobile Application Server. Successful attacks of this vulnerability can result in unauthorized access to critical data or complete access to all Oracle Mobile Application Server accessible data as well as unauthorized update, insert or delete access to some of Oracle Mobile Application Server accessible data and unauthorized ability to cause a hang or frequently repeatable crash (complete DOS) of Oracle Mobile Application Server. CVSS 3.1 Base Score 6.7 (Confidentiality, Integrity and Availability impacts). CVSS Vector: (CVSS:3.1/AV:N/AC:L/PR:H/UI:N/S:U/C:H/I:L/A:H).
- CVSS
- 6.7 MEDIUM (v3.1, NVD)CVSS:3.1/AV:N/AC:L/PR:H/UI:N/S:U/C:H/I:L/A:H
- Weakness (CWE)
- CWE-284, CWE-400
- Known exploited
- Not in CISA's KEV catalog
- EPSS (exploitation in the next 30 days)
- Not loaded for this CVE
- Assigned by
- Not given
- NVD analysis
- Analyzed
- Record last updated
- Aug 19, 2026
- First seen by InfoSec Signals
- Oct 9, 2026
Affected products
oracle e-business_suite oracle:e-business_suite | from 12.2.3 through 12.2.15 | NVD |
References
- https://www.oracle.com/security-alerts/cpujul2026.htmlvendor-advisory
The CVE record on cve.org NVD's entry
The CVE record is authoritative. Products marked “from the name” were identified from the CNA's free-text names, not a CPE, and are matched less certainly. This product uses the NVD API but is not endorsed or certified by the NVD.